Soumen Bhattacharyya: Clinical Implications and Risks in Metformin-Induced Vitamin B12 Deficiency
Soumen Bhattacharyya, College Teacher in the Department of Physiology at RBC College for Women, shared a post on LinkedIn:
“Metformin, Vitamin B12 Deficiency and Homocysteine: An Overlooked Clinical Link.
Metformin remains the cornerstone therapy for due to its efficacy, safety, and cardiovascular benefits.
However, an important long-term adverse effect often goes under-recognized: vitamin B12 deficiency and its metabolic consequences.
What’s the mechanism?
Metformin interferes with the calcium-dependent absorption of the intrinsic factor–vitamin B12 complex in the terminal ileum.
Additional contributing factors include altered gut motility and possible bacterial overgrowth.
Over time, this leads to reduced serum B12 levels.
Why does this matter?
Vitamin B12 plays a critical role in the conversion of homocysteine to methionine.
When B12 levels fall:
- Homocysteine accumulates
- Leads to a state of hyperhomocysteinemia
Clinical implications:
- Peripheral neuropathy (may mimic or worsen diabetic neuropathy)
- Megaloblastic anemia
- Increased cardiovascular risk associated with elevated homocysteine
What does the evidence say?
- Long-term metformin therapy is significantly associated with reduced B12 levels (de Jager et al., 2010)
- Reviews highlight impaired absorption as the primary mechanism (Niafar et al., 2021)
- Systematic analyses show increased homocysteine, particularly without vitamin supplementation (Aroda et al., 2016)
Clinical takeaway:
- Consider periodic monitoring of vitamin B12 in long-term metformin users
- Supplementation (oral or parenteral) when deficiency is detected
- Evaluate unexplained neuropathy carefully—don’t attribute everything to diabetes
Key References:
- de Jager J et al. Long-term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency. BMJ, 2010.
- Niafar M et al. Long-term metformin therapy and vitamin B12 deficiency. (Review, PMC8311483)
- Aroda VR et al. Metformin and vitamin B12 deficiency: a systematic review.
A simple intervention—monitoring B12—can prevent significant morbidity in millions of patients on metformin.”

Stay updated with Hemostasis Today.
-
May 12, 2026, 16:46Tagreed Alkaltham: Why Apheresis Matters in Modern Transfusion Medicine
-
May 12, 2026, 16:37Reinhold Kreutz: Cardiovascular Burden in Acute Intermittent Porphyria Needs Greater Awareness
-
May 12, 2026, 16:33Pablo Corral: The Truth About Very Low LDL-Cholesterol
-
May 12, 2026, 16:24Mildred Lundgren: We Must Talk About the Invisible Causes of Stroke
-
May 12, 2026, 16:17Irene Scala: The Sex Disparities In Access to Acute Stroke Treatments In Italy
-
May 12, 2026, 16:04May Nour: UCLA Health Mobile Stroke Unit Becomes The 1st In The World to Perform mCTA In the Field
-
May 12, 2026, 15:57Leonardo Roever: Prognostic Impact of Lipoprotein(a) and CAR in Elderly Acute Ischemic Stroke Patients
-
May 12, 2026, 15:54Bruno Pougault: Prioritizing Laboratory Tests in Resource-Limited Emergency Care
-
May 12, 2026, 15:37Jennifer Holter Chakrabarty: Supporting the Next Generation of Hematology Researchers